Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actelion

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Actelion's 2013 sales performance.

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ French pharma firm offers $105 apiece for the spin-out’s shares. After missing out on earlier bids for Medivation and Actelion, Sanofi has agreed to buy Biogen haematology spin-out ... Medivation in 2016 and was also trumped by Johnson &Johnson after

After some big setbacks, Sanofi talks up its R&D portfolio

After some big setbacks, Sanofi talks up its R&D portfolio However, it has tried and failed to make two pipeline-boosting acquisitions of late, losing out out to rivals bidding for Actelion and Medivation.

J&J files would-be prostate cancer blockbuster in US

J&J files would-be prostate cancer blockbuster in US They also suggest that J&J’s recent acquisition of Actelion will help sales growth accelerate.

Biosimilars eat into J&J's Remicade sales

Biosimilars eat into J&J's Remicade sales This is the first set of financial results for J&J since it closed the acquisition of Swiss biotech Actelion, a specialist in pulmonary arterial hypertension (PAH), on June 16.

J&J's Jane Griffiths named global head of Actelion

J&J's Jane Griffiths named global head of Actelion Griffiths is currently company group chairman at J&J’s Janssen EMEA company and will step into her new role once its purchase of Actelion is completed. ... Clozel will also take on new responsibilities, keeping control of Actelion’s early-stage

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
KVA

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...